Global Point of Care
Webinars
The diagnosis moment: the role of POCT HbA1c in undiagnosed diabetes and prediabetes in slowing the progression of diabetes and improving health equity
Published July 22, 2021
Summary
In this webinar a group of experts form the USA and UK will analyse how rapid point-of-care testing for HbA1c may benefit patients and support screening for undiagnosed diabetes and prediabetes.
Approximately 98 million American adults – more than 1 in 3 have prediabetes. Of those with prediabetes, more than 80% don’t know they have it. Prediabetes puts you at increased risk of developing type 2 diabetes, heart disease and stroke.1,2
This webinar is chaired by Dr. David Kerr, Director of research and innovation at Sansum Diabetes Research Institute (SDRI) USA. Dr Kerr launched the Mil Familias and Latino Diabetes programs at SDRI as part of a long-term initiative to reduce the disproportionate burden of cardio-metabolic disease affecting U.S Hispanic/Latino families. He also launched the farming for life program at SDRI which examines the impact of medical prescriptions for vegetables among adults with or at risk of type 2 diabetes. Dr. Kerr discusses the value of HbA1c point-of-care testing for underserved communities.
Dr.Yassir Javaid is Cardiovascular lead Nene ICS, Primary Care Cardiovascular lead, East Midlands Clinical Network. Dr, Javaid will discuss the importance of the early identification of diabetes and pre-diabetes the UK perspective.
Dr. Jay Shubrook is a diabetologist and family physician in Vacaville, California. He serves as professor and director of Clinical Research at Touro University California and also serves as the director of Diabetes services. Dr. Schubrook starts the webinar by discussing how to better prepare the primary care workforce to manage diabetes and obesity-related diseases with the support of point-of-care testing for HbA1c.
Learning Objectives
- Understand how point-of-care HbA1c testing supports early detection and timely management of diabetes to improve patient outcomes.
- Understand the value of HbA1c point-of-care testing for underserved communities.
- The role of HbA1c point-of-care testing in detecting prediabetes and the advantages of early diabetes diagnosis for improving cardiometabolic health.
- Leveraging point-of-care HbA1c and continuous glucose monitoring (CGM) to enhance diabetes assessment.
- Recognize the critical role of early detection in managing diabetes and pre-diabetes.
- How to better address diabetes and pre-diabetes from a primary care standpoint.
References
- Centers for Disease Control and Prevention. (2023, October 18). Prediabetes: Could it be you? CDC. Retrieved May 22, 2025, from https://www.cdc.gov/diabetes/communication-resources/prediabetes-statistics.html
- Centers for Disease Control and Prevention. (n.d.). Prediabetes Report Card. CDC. Retrieved May 22, 2025, from https://archive.cdc.gov/www_cdc_gov/diabetes/library/reports/reportcard/prediabetes.html
Presenter Biography
Dr. David Kerr
Chair
USA
Utilizing HbA1c Point-of-care testing in underserved communities
Dr. Yassir Javaid
Speaker
England
The importance of the early identification of diabetes and pre-diabetes
Dr. Jay Shubrook
USA
Preparing the primary care workforce to better manage diabetes by optimizing the prevention and treatment of diabetes
Who Should Watch
Endocrinologists, Mental Health Practitioners, Psychiatrists, Cardiologists Primary Care Physicians, Nephrologists, Healthcare professionals, Clinicians, POC coordinators, Physicians, General practitioners